DENVER--(Business Wire)--LABS Inc. has finalized the agreement to acquire the assets of
Laboratories at Bonfils - a subsidiary of Bonfils blood center. The
parties closed the final agreement on November 30th, 2007.
LABS Inc. is the Country's leading testing facility for the
specialized needs of organ procurement organizations, eye and tissue
banks. LABS Inc. will continue to provide donor eligibility testing
for the human eye, tissue, reproductive, stem cell and solid organ
transplant industry.
"LABS Inc. will continue to provide the most accurate,
high-quality and timely testing methods for the transplant community,"
said Elizabeth Hearty, chief executive officer of LABS Inc. "We look
forward to working with industry leaders in a consultative and
partnering manner to consistently improve the delivery and efficiency
of our quality laboratory services for organizations across the
country."
LABS Inc. is a nonprofit, taxable affiliate of AlloSource, a
Colorado-based, nonprofit provider of bone and soft tissue allografts
to local communities. LABS Inc. retains its own management team
reporting to an independent board of directors. All current
Laboratories at Bonfils staff, including senior management, PhDs and
highly qualified laboratory personnel, have been retained by LABS Inc.
to continue to provide unparalleled consultative expertise and
industry knowledge to customers.
About LABS Inc.
LABS Inc., based in Denver, Colorado, is one of the premier
transplant medicine reference laboratories in the country. Testing is
focused on donor eligibility determination and final product safety,
infectious disease testing, microbiology, histocompatibilty and
environmental monitoring. LABS Inc. is committed to respectfully
fulfilling the wishes of donors by ensuring the gift is able to
generate positive patient outcomes. LABS Inc. employs over 100 people.
For LABS Inc.
Jennifer Tramontana, 303-929-9636
jennifer@fletchergroupllc.com
Copyright Business Wire 2007
